CYPH — Cypherpunk Technologies Share News
0.000.00%
Last trade - 00:00- $321.14m
- $313.51m
Leap Therapeutics Inc expected to post a loss of 58 cents a share - Earnings Preview
Brief: Gilead Sciences Reports 13.9% Passive Stake In Leap Therapeutics As Of April 10- SEC Filing
Brief: Leap Therapeutics Announces $40 Mln Private Placement
U.S. RESEARCH ROUNDUP-American Tower, Lennar, Nike
Leap Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Leap Therapeutics Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
U.S. STOCKS ON THE MOVE-Bullfrog AI, Sinclair, Humana
U.S. STOCKS ON THE MOVE-Snap, Charles Schwab, Tesla
U.S. STOCKS ON THE MOVE-premarket
Leap Therapeutics rises as cancer therapy shows promise in mid-stage study
Brief: Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium
Brief: Leap Therapeutics Announces Enrollment Completion in Randomized Controlled Part C of the DisTinGuish Study of DKN-01
U.S. STOCKS ON THE MOVE-SciSparc Ltd, iRobot Corp, Vista Outdoor Inc
U.S. RESEARCH ROUNDUP-Aclaris Therapeutics, Beauty Health Co, Vicarious Surgical
U.S. RESEARCH ROUNDUP-Dollar Tree, Hexcel, Humacyte
Leap Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Leap Therapeutics Inc expected to post a loss of 90 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Diamondback Energy, Penumbra, Procore Technologies
Leap Therapeutics plunges on 10-for-1 reverse stock split